Overview

Study In Patients With Overactive Bladder Treated With ToviazĀ® After Failure Of Previous Therapy

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
This is a observational study in patients treated with fesoterodine (Toviaz), who have failed on previous treatment for overactive bladder. It will collect epidemiological data and investigate the efficacy and tolerability of fesoterodine.
Details
Lead Sponsor:
Pfizer
Treatments:
Fesoterodine